136 related articles for article (PubMed ID: 32089267)
1. From transglutaminases (TGs) to arylamine N-acetyltransferases (NATs): Insight into the role of a spatially conserved aromatic amino acid position in the active site of these two families of enzymes.
Xu X; Zhang W; Berthelet J; Liu R; Michail C; Chaffotte AF; Dupret JM; Rodrigues-Lima F
Biochem Biophys Res Commun; 2020 Apr; 525(2):308-312. PubMed ID: 32089267
[TBL] [Abstract][Full Text] [Related]
2. Structural and biochemical characterization of an active arylamine N-acetyltransferase possessing a non-canonical Cys-His-Glu catalytic triad.
Kubiak X; Li de la Sierra-Gallay I; Chaffotte AF; Pluvinage B; Weber P; Haouz A; Dupret JM; Rodrigues-Lima F
J Biol Chem; 2013 Aug; 288(31):22493-505. PubMed ID: 23770703
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines.
Sandy J; Mushtaq A; Holton SJ; Schartau P; Noble ME; Sim E
Biochem J; 2005 Aug; 390(Pt 1):115-23. PubMed ID: 15869465
[TBL] [Abstract][Full Text] [Related]
4. Eubacterial arylamine N-acetyltransferases - identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues.
Payton M; Mushtaq A; Yu TW; Wu LJ; Sinclair J; Sim E
Microbiology (Reading); 2001 May; 147(Pt 5):1137-1147. PubMed ID: 11320117
[TBL] [Abstract][Full Text] [Related]
5. Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop.
Rodrigues-Lima F; Deloménie C; Goodfellow GH; Grant DM; Dupret JM
Biochem J; 2001 Jun; 356(Pt 2):327-34. PubMed ID: 11368758
[TBL] [Abstract][Full Text] [Related]
6. Structure and mechanism of arylamine N-acetyltransferases.
Westwood IM; Kawamura A; Fullam E; Russell AJ; Davies SG; Sim E
Curr Top Med Chem; 2006; 6(15):1641-54. PubMed ID: 16918475
[TBL] [Abstract][Full Text] [Related]
7. Probing the catalytic potential of the hamster arylamine N-acetyltransferase 2 catalytic triad by site-directed mutagenesis of the proximal conserved residue, Tyr190.
Zhou X; Zhang N; Liu L; Walters KJ; Hanna PE; Wagner CR
FEBS J; 2009 Dec; 276(23):6928-41. PubMed ID: 19860825
[TBL] [Abstract][Full Text] [Related]
8. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
9. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M
Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167
[TBL] [Abstract][Full Text] [Related]
10. The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity.
Mushtaq A; Payton M; Sim E
J Biol Chem; 2002 Apr; 277(14):12175-81. PubMed ID: 11799105
[TBL] [Abstract][Full Text] [Related]
11. Purification, crystallization and preliminary X-ray characterization of Bacillus cereus arylamine N-acetyltransferase 3 [(BACCR)NAT3].
Kubiak X; Pluvinage B; Li de la Sierra-Gallay I; Weber P; Haouz A; Dupret JM; Rodrigues-Lima F
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Feb; 68(Pt 2):196-8. PubMed ID: 22297998
[TBL] [Abstract][Full Text] [Related]
12. The pharmacogenetics of NAT: structural aspects.
Pompeo F; Brooke E; Kawamura A; Mushtaq A; Sim E
Pharmacogenomics; 2002 Jan; 3(1):19-30. PubMed ID: 11966400
[TBL] [Abstract][Full Text] [Related]
13. The conserved glycine/alanine residue of the active-site loop containing the putative acetylCoA-binding motif is essential for the overall structural integrity of Mesorhizobium loti arylamine N-acetyltransferase 1.
Atmane N; Dairou J; Flatters D; Martins M; Pluvinage B; Derreumaux P; Dupret JM; Rodrigues-Lima F
Biochem Biophys Res Commun; 2007 Sep; 361(1):256-62. PubMed ID: 17658468
[TBL] [Abstract][Full Text] [Related]
14. Catalytic mechanism of hamster arylamine N-acetyltransferase 2.
Wang H; Liu L; Hanna PE; Wagner CR
Biochemistry; 2005 Aug; 44(33):11295-306. PubMed ID: 16101314
[TBL] [Abstract][Full Text] [Related]
15. Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis.
Deloménie C; Goodfellow GH; Krishnamoorthy R; Grant DM; Dupret JM
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):207-15. PubMed ID: 9173883
[TBL] [Abstract][Full Text] [Related]
16. Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity.
Murthy SN; Iismaa S; Begg G; Freymann DM; Graham RM; Lorand L
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2738-42. PubMed ID: 11867764
[TBL] [Abstract][Full Text] [Related]
17. Arylamine N-acetyltransferases: from structure to function.
Sim E; Walters K; Boukouvala S
Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
[TBL] [Abstract][Full Text] [Related]
18. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
[TBL] [Abstract][Full Text] [Related]
19. Arylamine N-acetyltransferases: what we learn from genes and genomes.
Boukouvala S; Fakis G
Drug Metab Rev; 2005; 37(3):511-64. PubMed ID: 16257833
[TBL] [Abstract][Full Text] [Related]
20. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]